Targeting of aquaporin 4 into lipid rafts and its biological significance

Kunihiko Asakura, Akihiro Ueda, Sayuri Shima, Tomomasa Ishikawa, Chika Hikichi, Seiko Hirota, Takao Fukui, Shinji Ito, Tatsuro Mutoh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system and is considered to be caused by the binding of NMO-IgG to aquaporin 4 (AQP4) on astrocytes, which initiates complement-dependent cytotoxicity. AQP4 has two isoforms, i.e., M1 and M23. AQP4 is considered to form heterotetramers containing both isoforms in vivo. Most of the previous studies were performed using either one of the isoforms expressing cell lines. In this study, we generated a fluorescent epitope-tagged AQP4 M1 and M23 co-expressing astrocyte cell line and examined the subcellular targeting of AQP4. In this cell line, AQP4 was targeted mostly to membrane lipid rafts fraction evidenced by sucrose density gradient ultracentrifugation followed by Western blotting with anti-AQP4 antibody. Cholesterol depletion with methyl-p-cyclodextrin or simvastatin resulted in the dislocation (relocation) of AQP4 from lipid rafts to non-rafts fraction of the membrane and AQP4 was not internalized intracellularly. This change in the localization of AQP4 on membrane significantly reduced complement-dependent cytotoxic effects of NMO-IgG obtained from patients with NMO without affecting AQP4 orthogonal arrays. Thus, these data strongly suggest that the targeting of AQP4 in the lipid rafts is closely related to the pathogenic effects of NMO-IgG.

Original languageEnglish
Pages (from-to)237-244
Number of pages8
JournalBrain Research
Volume1583
Issue number1
DOIs
Publication statusPublished - 01-01-2014

Fingerprint

Aquaporin 4
Lipids
Neuromyelitis Optica
Protein Isoforms
Immunoglobulin G
Cell Line
Astrocytes
Simvastatin
Membranes
Ultracentrifugation
Cyclodextrins
Demyelinating Diseases
Membrane Lipids
Sucrose
Epitopes

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Asakura, K., Ueda, A., Shima, S., Ishikawa, T., Hikichi, C., Hirota, S., ... Mutoh, T. (2014). Targeting of aquaporin 4 into lipid rafts and its biological significance. Brain Research, 1583(1), 237-244. https://doi.org/10.1016/j.brainres.2014.08.014
Asakura, Kunihiko ; Ueda, Akihiro ; Shima, Sayuri ; Ishikawa, Tomomasa ; Hikichi, Chika ; Hirota, Seiko ; Fukui, Takao ; Ito, Shinji ; Mutoh, Tatsuro. / Targeting of aquaporin 4 into lipid rafts and its biological significance. In: Brain Research. 2014 ; Vol. 1583, No. 1. pp. 237-244.
@article{40476baa821d436fb91d939db4e3cc6f,
title = "Targeting of aquaporin 4 into lipid rafts and its biological significance",
abstract = "Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system and is considered to be caused by the binding of NMO-IgG to aquaporin 4 (AQP4) on astrocytes, which initiates complement-dependent cytotoxicity. AQP4 has two isoforms, i.e., M1 and M23. AQP4 is considered to form heterotetramers containing both isoforms in vivo. Most of the previous studies were performed using either one of the isoforms expressing cell lines. In this study, we generated a fluorescent epitope-tagged AQP4 M1 and M23 co-expressing astrocyte cell line and examined the subcellular targeting of AQP4. In this cell line, AQP4 was targeted mostly to membrane lipid rafts fraction evidenced by sucrose density gradient ultracentrifugation followed by Western blotting with anti-AQP4 antibody. Cholesterol depletion with methyl-p-cyclodextrin or simvastatin resulted in the dislocation (relocation) of AQP4 from lipid rafts to non-rafts fraction of the membrane and AQP4 was not internalized intracellularly. This change in the localization of AQP4 on membrane significantly reduced complement-dependent cytotoxic effects of NMO-IgG obtained from patients with NMO without affecting AQP4 orthogonal arrays. Thus, these data strongly suggest that the targeting of AQP4 in the lipid rafts is closely related to the pathogenic effects of NMO-IgG.",
author = "Kunihiko Asakura and Akihiro Ueda and Sayuri Shima and Tomomasa Ishikawa and Chika Hikichi and Seiko Hirota and Takao Fukui and Shinji Ito and Tatsuro Mutoh",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.brainres.2014.08.014",
language = "English",
volume = "1583",
pages = "237--244",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

Asakura, K, Ueda, A, Shima, S, Ishikawa, T, Hikichi, C, Hirota, S, Fukui, T, Ito, S & Mutoh, T 2014, 'Targeting of aquaporin 4 into lipid rafts and its biological significance', Brain Research, vol. 1583, no. 1, pp. 237-244. https://doi.org/10.1016/j.brainres.2014.08.014

Targeting of aquaporin 4 into lipid rafts and its biological significance. / Asakura, Kunihiko; Ueda, Akihiro; Shima, Sayuri; Ishikawa, Tomomasa; Hikichi, Chika; Hirota, Seiko; Fukui, Takao; Ito, Shinji; Mutoh, Tatsuro.

In: Brain Research, Vol. 1583, No. 1, 01.01.2014, p. 237-244.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeting of aquaporin 4 into lipid rafts and its biological significance

AU - Asakura, Kunihiko

AU - Ueda, Akihiro

AU - Shima, Sayuri

AU - Ishikawa, Tomomasa

AU - Hikichi, Chika

AU - Hirota, Seiko

AU - Fukui, Takao

AU - Ito, Shinji

AU - Mutoh, Tatsuro

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system and is considered to be caused by the binding of NMO-IgG to aquaporin 4 (AQP4) on astrocytes, which initiates complement-dependent cytotoxicity. AQP4 has two isoforms, i.e., M1 and M23. AQP4 is considered to form heterotetramers containing both isoforms in vivo. Most of the previous studies were performed using either one of the isoforms expressing cell lines. In this study, we generated a fluorescent epitope-tagged AQP4 M1 and M23 co-expressing astrocyte cell line and examined the subcellular targeting of AQP4. In this cell line, AQP4 was targeted mostly to membrane lipid rafts fraction evidenced by sucrose density gradient ultracentrifugation followed by Western blotting with anti-AQP4 antibody. Cholesterol depletion with methyl-p-cyclodextrin or simvastatin resulted in the dislocation (relocation) of AQP4 from lipid rafts to non-rafts fraction of the membrane and AQP4 was not internalized intracellularly. This change in the localization of AQP4 on membrane significantly reduced complement-dependent cytotoxic effects of NMO-IgG obtained from patients with NMO without affecting AQP4 orthogonal arrays. Thus, these data strongly suggest that the targeting of AQP4 in the lipid rafts is closely related to the pathogenic effects of NMO-IgG.

AB - Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system and is considered to be caused by the binding of NMO-IgG to aquaporin 4 (AQP4) on astrocytes, which initiates complement-dependent cytotoxicity. AQP4 has two isoforms, i.e., M1 and M23. AQP4 is considered to form heterotetramers containing both isoforms in vivo. Most of the previous studies were performed using either one of the isoforms expressing cell lines. In this study, we generated a fluorescent epitope-tagged AQP4 M1 and M23 co-expressing astrocyte cell line and examined the subcellular targeting of AQP4. In this cell line, AQP4 was targeted mostly to membrane lipid rafts fraction evidenced by sucrose density gradient ultracentrifugation followed by Western blotting with anti-AQP4 antibody. Cholesterol depletion with methyl-p-cyclodextrin or simvastatin resulted in the dislocation (relocation) of AQP4 from lipid rafts to non-rafts fraction of the membrane and AQP4 was not internalized intracellularly. This change in the localization of AQP4 on membrane significantly reduced complement-dependent cytotoxic effects of NMO-IgG obtained from patients with NMO without affecting AQP4 orthogonal arrays. Thus, these data strongly suggest that the targeting of AQP4 in the lipid rafts is closely related to the pathogenic effects of NMO-IgG.

UR - http://www.scopus.com/inward/record.url?scp=84922681700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922681700&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2014.08.014

DO - 10.1016/j.brainres.2014.08.014

M3 - Article

VL - 1583

SP - 237

EP - 244

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -